Gilead Historical Financial Ratios
| GILD Stock | USD 67.08 0.05 0.07% |
Gilead Sciences is recently reporting on over 113 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 7.85 or Days Sales Outstanding of 59.59 will help investors to properly organize and evaluate Gilead Sciences financial condition quickly.
Gilead |
About Gilead Financial Ratios Analysis
Gilead SciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Gilead Sciences investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Gilead financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Gilead Sciences history.
Gilead Sciences Financial Ratios Chart
Gilead Sciences financial ratios usually calculated using numerical values taken directly from Gilead Sciences financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Gilead Sciences. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
At present, Gilead Sciences' PTB Ratio is projected to drop slightly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 19.14, whereas Days Sales Outstanding is forecasted to decline to 59.59. Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Gilead Sciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Gilead Sciences sales, a figure that is much harder to manipulate than other Gilead Sciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Gilead Sciences dividend as a percentage of Gilead Sciences stock price. Gilead Sciences dividend yield is a measure of Gilead Sciences stock productivity, which can be interpreted as interest rate earned on an Gilead Sciences investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Most ratios from Gilead Sciences' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Gilead Sciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.At present, Gilead Sciences' PTB Ratio is projected to drop slightly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 19.14, whereas Days Sales Outstanding is forecasted to decline to 59.59.
| 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0395 | 0.0344 | 0.0377 | 0.0485 | Price To Sales Ratio | 3.34 | 3.95 | 3.73 | 3.54 |
Gilead Sciences fundamentals Correlations
Click cells to compare fundamentals
Gilead Sciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Gilead Sciences fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 3.68 | 2.97 | 3.34 | 3.95 | 3.73 | 3.54 | |
| Dividend Yield | 0.039 | 0.0471 | 0.0395 | 0.0344 | 0.0377 | 0.0485 | |
| Ptb Ratio | 3.64 | 4.02 | 4.33 | 5.08 | 4.44 | 7.85 | |
| Days Sales Outstanding | 58.24 | 72.32 | 60.06 | 63.91 | 62.73 | 59.59 | |
| Book Value Per Share | 17.83 | 14.5 | 16.77 | 16.9 | 18.23 | 19.14 | |
| Free Cash Flow Yield | 0.12 | 0.0921 | 0.1 | 0.0774 | 0.0734 | 0.0771 | |
| Invested Capital | 1.27 | 1.09 | 1.72 | 1.19 | 1.1 | 1.15 | |
| Operating Cash Flow Per Share | 7.2 | 6.5 | 9.06 | 7.23 | 6.42 | 6.74 | |
| Stock Based Compensation To Revenue | 0.0382 | 0.0283 | 0.026 | 0.0233 | 0.0282 | 0.0415 | |
| Pb Ratio | 3.64 | 4.02 | 4.33 | 5.08 | 4.44 | 7.85 | |
| Ev To Sales | 4.25 | 4.0 | 4.12 | 4.68 | 4.43 | 4.2 | |
| Free Cash Flow Per Share | 6.55 | 5.98 | 8.6 | 6.65 | 5.95 | 6.24 | |
| Inventory Turnover | 5.96 | 2.26 | 1.52 | 2.41 | 2.01 | 1.77 | |
| Net Income Per Share | 4.24 | 0.0708 | 4.96 | 3.66 | 4.54 | 4.77 | |
| Days Of Inventory On Hand | 161.38 | 240.62 | 151.18 | 181.95 | 205.86 | 269.81 | |
| Payables Turnover | 6.56 | 5.42 | 9.36 | 6.25 | 10.85 | 11.39 | |
| Capex To Revenue | (0.0367) | (0.0263) | (0.0212) | (0.0267) | (0.0216) | (0.0227) | |
| Cash Per Share | 19.17 | 5.89 | 5.19 | 5.09 | 5.82 | 3.08 | |
| Pocfratio | 9.03 | 8.97 | 8.01 | 11.88 | 12.63 | 13.26 | |
| Interest Coverage | 4.31 | 7.14 | 7.4 | 7.84 | 9.92 | 11.54 | |
| Payout Ratio | 0.6 | 38.75 | 0.58 | 0.81 | 0.67 | 0.64 | |
| Capex To Operating Cash Flow | (0.0902) | (0.0796) | (0.0509) | (0.0802) | (0.0731) | (0.0694) | |
| Pfcf Ratio | 9.92 | 9.74 | 8.44 | 12.91 | 13.62 | 14.3 | |
| Days Payables Outstanding | 55.67 | 67.38 | 38.98 | 58.39 | 33.64 | 23.74 | |
| Income Quality | 1.7 | 91.78 | 1.84 | 1.99 | 1.43 | 1.36 | |
| Roe | 0.23 | 0.25 | 0.24 | 0.004884 | 0.3 | 0.22 | |
| Ev To Operating Cash Flow | 10.44 | 12.08 | 9.89 | 14.06 | 14.99 | 15.74 | |
| Pe Ratio | 15.32 | 822.84 | 14.65 | 23.46 | 17.85 | 20.47 | |
| Ev To Free Cash Flow | 11.48 | 13.12 | 10.42 | 15.29 | 16.17 | 16.98 | |
| Earnings Yield | 0.0653 | 0.001215 | 0.0683 | 0.0426 | 0.056 | 0.0588 | |
| Intangibles To Total Assets | 0.3 | 0.31 | 0.29 | 0.61 | 0.59 | 0.56 | |
| Net Debt To E B I T D A | 1.06 | 2.11 | 2.99 | 2.26 | 1.91 | 0.94 | |
| Current Ratio | 3.36 | 3.23 | 1.39 | 1.3 | 1.36 | 1.46 | |
| Tangible Book Value Per Share | 3.74 | (18.31) | (16.5) | (12.75) | (9.63) | (9.15) | |
| Receivables Turnover | 6.27 | 5.05 | 6.08 | 5.71 | 5.82 | 3.9 |
Gilead Sciences Investors Sentiment
The influence of Gilead Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Gilead. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Gilead Sciences' public news can be used to forecast risks associated with an investment in Gilead. The trend in average sentiment can be used to explain how an investor holding Gilead can time the market purely based on public headlines and social activities around Gilead Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Gilead Sciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Gilead Sciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Gilead Sciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Gilead Sciences.
Gilead Sciences Implied Volatility | 60.6 |
Gilead Sciences' implied volatility exposes the market's sentiment of Gilead Sciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Gilead Sciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Gilead Sciences stock will not fluctuate a lot when Gilead Sciences' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Gilead Sciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Gilead Sciences' short interest history, or implied volatility extrapolated from Gilead Sciences options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Gilead Stock analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Dividend Share 3 | Earnings Share 4.5 | Revenue Per Share 21.728 | Quarterly Revenue Growth (0.04) |
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.